Liquidia LQDA Stock
15.35 USD
{{ price }}
-1.349615%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
1.31B USD
LOW - HIGH [24H]
15.01
-
17.88 USD
VOLUME [24H]
4.7M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.71 USD
Liquidia Price Chart
Liquidia LQDA Financial and Trading Overview
| Liquidia stock price | 15.35 USD |
| Previous Close | 7.87 USD |
| Open | 7.85 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 1800 |
| Day's Range | 7.52 - 8.28 USD |
| 52 Week Range | 3.38 - 8.99 USD |
| Volume | 882.8K USD |
| Avg. Volume | 433.71K USD |
| Market Cap | 535.21M USD |
| Beta (5Y Monthly) | 0.07829 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.71 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.29 USD |
LQDA Valuation Measures
| Enterprise Value | 449.8M USD |
| Trailing P/E | N/A |
| Forward P/E | -9.963856 |
| PEG Ratio (5 yr expected) | -0.07 |
| Price/Sales (ttm) | 31.602135 |
| Price/Book (mrq) | 6.553091 |
| Enterprise Value/Revenue | 26.559 |
| Enterprise Value/EBITDA | -14.252 |
Trading Information
Liquidia Stock Price History
| Beta (5Y Monthly) | 0.07829 |
| 52-Week Change | 70.16% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 8.99 USD |
| 52 Week Low | 3.38 USD |
| 50-Day Moving Average | 7.57 USD |
| 200-Day Moving Average | 6.42 USD |
LQDA Share Statistics
| Avg. Volume (3 month) | 433.71K USD |
| Avg. Daily Volume (10-Days) | 535.34K USD |
| Shares Outstanding | 64.72M |
| Float | 47.32M |
| Short Ratio | 3.57 |
| % Held by Insiders | 13.78% |
| % Held by Institutions | 52.15% |
| Shares Short | 1.85M |
| Short % of Float | 4.95% |
| Short % of Shares Outstanding | 2.85% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -217.38% |
| Operating Margin (ttm) | -197.98% |
| Gross Margin | 83.35% |
| EBITDA Margin | -186.35% |
Management Effectiveness
| Return on Assets (ttm) | -18.84% |
| Return on Equity (ttm) | -53.73% |
Income Statement
| Revenue (ttm) | 16.94M USD |
| Revenue Per Share (ttm) | 0.27 USD |
| Quarterly Revenue Growth (yoy) | 28.69% |
| Gross Profit (ttm) | 13.08M USD |
| EBITDA | -31561000 USD |
| Net Income Avi to Common (ttm) | -36817000 USD |
| Diluted EPS (ttm) | -0.53 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 94.41M USD |
| Total Cash Per Share (mrq) | 1.46 USD |
| Total Debt (mrq) | 34.88M USD |
| Total Debt/Equity (mrq) | 42.73 USD |
| Current Ratio (mrq) | 14.617 |
| Book Value Per Share (mrq) | 1.262 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -27263000 USD |
| Levered Free Cash Flow (ttm) | -15014250 USD |
Profile of Liquidia
| Country | United States |
| State | NC |
| City | Morrisville |
| Address | 419 Davis Drive |
| ZIP | 27560 |
| Phone | 919 328 4400 |
| Website | https://www.liquidia.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 63 |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. The company distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Q&A For Liquidia Stock
What is a current LQDA stock price?
Liquidia LQDA stock price today per share is 15.35 USD.
How to purchase Liquidia stock?
You can buy LQDA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Liquidia?
The stock symbol or ticker of Liquidia is LQDA.
Which industry does the Liquidia company belong to?
The Liquidia industry is Biotechnology.
How many shares does Liquidia have in circulation?
The max supply of Liquidia shares is 85.48M.
What is Liquidia Price to Earnings Ratio (PE Ratio)?
Liquidia PE Ratio is now.
What was Liquidia earnings per share over the trailing 12 months (TTM)?
Liquidia EPS is -1.71 USD over the trailing 12 months.
Which sector does the Liquidia company belong to?
The Liquidia sector is Healthcare.
Liquidia LQDA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 18737.21 USD — |
-1
|
7.88B USD — | 18599.69 USD — | 18841.52 USD — | — - | 7.88B USD — |
| NASDAQ Capital Market Composite RCMP | 112.43 USD — |
+0.26
|
— — | 109.69 USD — | 112.55 USD — | — - | — — |
| Nasdaq Health Care IXHC | 932.02 USD — |
-0.03
|
— — | 920.46 USD — | 933.54 USD — | — - | — — |
- {{ link.label }} {{link}}